GI Effects Comprehensive Profile (GIFX)

GI Effects is an innovative stool test measuring premier biomarkers of gastrointestinal function, providing valuable clinical insight into digestive performance, gut inflammation, and the gut microbiome — areas affecting not only GI health, but overall health as well. Functional testing can help uncover the root cause of many chronic conditions that often frustrate both physician […]

GI Effects is an innovative stool test measuring premier biomarkers of gastrointestinal function, providing valuable clinical insight into digestive performance, gut inflammation, and the gut microbiome — areas affecting not only GI health, but overall health as well.

Functional testing can help uncover the root cause of many chronic conditions that often frustrate both physician and patient. The scope of the biomarkers on the GI Effects Stool Profile provides comprehensive information to the clinician for the development of strategic interventions. As identified functional imbalances and inadequacies become more normalized through targeted dietary, lifestyle, and supplementation therapeutics, intractable symptoms often improve for many patients.

Features include:

• Quick overview and synthesis of results reflecting the status of the 3 key functions of gut health arranged in the “DIG” format: digestion, inflammation, and the gut microbiome

• Functional imbalance scores that incorporate biomarkers belonging 5 functional categories: maldigestion, inflammation, dysbiosis, metabolic imbalance & infection

• Therapeutic support options to serve as potential treatment ideas

• A Commensal Balance Infographic, total & relative – Designed to provide a more precise view of an individual patient’s commensal bacteria (PCR) results relative to a spectrum of healthy and unhealthy commensal patterns.

• Including Inflammation-Associated Dysbiosis score & Methane Dysbiosis Score (Immune Suppression) to help guide therapy

• Clinical Association Charts – See how patient results compare to commensal bacteria (PCR) and biomarker patterns seen in patients with specific clinical conditions, such as IBS, IBD, Metabolic Syndrome, Chronic Fatigue, Autoimmune dysfunction, Type 2 Diabetes, High Blood Pressure and Mood Disorders.

Correlations are now evident between many disease processes and patterns of microbiome dysbiosis in both gut dysfunction and extra-intestinal disorders.

Indications

• Autism

• Autoimmune

• Cardiovascular Disease

• Celiac and Other Malabsorption Disorders

• Diabetes

• Inflammatory Bowel Disease (IBD)

• Irritable Bowel Syndrome (IBS)

• Mood Disorders

• Obesity

Copyright © Nordic Clinic 2020